Towards Response ADAptive Radiotherapy for organ preservation for intermediate-risk rectal cancer (preRADAR): protocol of a phase I dose-escalation trial. Maaike E Verweij , Max D Tanaka , Chavelli M Kensen , Uulke A van der Heide , Corrie A M Marijnen , Tomas Janssen , Tineke Vijlbrief , Wilhelmina M U van Grevenstein , Leon M G Moons , Miriam Koopman , Miangela M Lacle , Manon N G J A Braat , Myriam Chalabi , Monique Maas , Inge L Huibregtse , Petur Snaebjornsson , Brechtje A Grotenhuis , Remond Fijneman , Esther Consten , Apollo Pronk , Anke B Smits , Joost T Heikens , Hidde Eijkelenkamp , Sjoerd G Elias , Helena M Verkooijen , Maartje M C Schoenmakers , Gert J Meijer , Martijn Intven , Femke P Peters BMJ Open（2023）
摘要
WHO International Clinical Trials Registry (NL8997; https://trialsearch.who.int).
更多 查看译文
关键词
response adaptive radiotherapy, rectal cancer, organ preservation, intermediate-risk, dose-escalation
AI 理解论文
溯源树
样例
